Related Experiment Videos
Homocysteine metabolism.
1Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts 02111, USA. selhub_vb@hnrc.tufts.edu
Annual Review of Nutrition
|August 17, 1999
Summary
Elevated homocysteine levels, a marker for vascular disease risk, result from disruptions in its metabolism. Understanding these disruptions is key to addressing associated health risks.
Area of Science:
- Biochemistry
- Metabolic pathways
- Vascular biology
Background:
- Homocysteine metabolism involves remethylation and transsulfuration pathways, regulated by S-adenosylmethionine.
- Hyperhomocysteinemia, elevated homocysteine, is linked to increased vascular disease risk.
- Genetic defects and nutrient deficiencies (folate, B12, B6) can cause hyperhomocysteinemia.
Purpose of the Study:
- To elucidate the mechanisms underlying the association between mild hyperhomocysteinemia and vascular disease.
- To explore the multifactorial effects of elevated homocysteine on vascular health.
Main Methods:
- Review of epidemiological studies on homocysteine and vascular disease.
- Analysis of in vitro studies on homocysteine's effects on cells.
- Examination of animal models with mild hyperhomocysteinemia.
Main Results:
- Disrupted homocysteine metabolism leads to hyperhomocysteinemia and vascular disease risk.
- Animal models suggest elevated homocysteine affects vascular wall structure and coagulation.
- Mild hyperhomocysteinemia mechanisms are being elucidated through recent studies.
Conclusions:
- Hyperhomocysteinemia is a significant risk factor for vascular disease.
- Further research is needed to fully understand the complex mechanisms involved.
- Targeting homocysteine metabolism may offer therapeutic strategies for vascular disease prevention.